Login

Switch On Your HIV Smarts.

PrEP study now enrolling at Strut in San Francisco

PrEP study now enrolling at Strut in San Francisco

, by San Francisco AIDS Foundation

San Francisco AIDS Foundation is enrolling people into a study testing an investigational new drug for PrEP. Find out what the study’s about, and how to get involved. Read More

BREAKING NEWS: California cancels contract with ADAP administrator; HIV advocates hopeful for a better system

BREAKING NEWS: California cancels contract with ADAP administrator; HIV advocates hopeful for a better system

, by Emily Newman

HIV advocates are hopeful that the change will fix the ongoing problems ADAP has experienced, and improve the experience for ADAP clients. Read More

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

, by Liz Highleyman

Two new HIV drugs, an NNRTI and an integrase inhibitor, did well in clinical trials and are currently being tested as part of fixed-dose co-formulated pills. Read More

Research will see if antibodies can more selectively target & kill HIV-infected cells

Research will see if antibodies can more selectively target & kill HIV-infected cells

, by Emily Newman

In this Q&A, Galit Alter, PhD explains her research on broadly functional antibodies and if they can be used to rid the body of the latent HIV reservoir. Read More

Medicaid, the biggest HIV insurance provider, is seriously vulnerable under President Trump’s administration

Medicaid, the biggest HIV insurance provider, is seriously vulnerable under President Trump’s administration

, by Emily Newman

Block granting Medicaid will lead to funding cuts, say experts, which will impact people living with HIV and many others. Read More